LONDON, March 7, 2014 /PRNewswire/ --
On Thursday, March 06, 2014, the NASDAQ Composite finished at 4,352.13, down 0.13% for the day. The Dow Jones Industrial Average closed the session at 16,421.89, up 0.38% and the S&P 500 ended the day at 1,877.03, higher by 0.17%. The gains were broad based with 7 of 10 sectors going up. Investor-Edge.com looks at some of the equities that during the last session hit a new 52-week high. These include Brocade Communications Systems Inc.(NASDAQ:BRCD), Huntsman Corporation (NYSE:HUN), The Kroger Company (NYSE:KR), and Teva Pharmaceutical Industries Ltd (NYSE:TEVA). Free research on these five companies can be accessed at:
http://investor-edge.com/register
Brocade Communications Systems Inc.'s stock fluctuated in the range of $9.99 and $10.29 during Thursday's session, hitting a new 52-week high of $10.29. The company's stock reported a gain of 1.90%, ending the day at $10.20. A total of 12.76 million shares were traded, as compared to the 3-months average volume of 5.10 million shares. Brocade Communications Systems Inc.'s shares have surged 8.51% in the last one month and 18.60% in the previous three months. The S&P 500 Information Technology Sector Index posted gains of 1.64% in the previous three trading sessions and 5.85% in the last three months. Shares of the company traded at a PE ratio of 14.15 and were up 15.06% on YTD basis. The company's stock is trading above its 50-day and 200-day moving averages of $9.32 and $7.79, respectively. The stock's RSI stood at 68.58. Sign up and read the free notes on BRCD at:
http://www.Investor-Edge.com/03072014/BRCD/report.pdf
On Thursday, Huntsman Corp.'s stock finished the day at $24.59, up 1.11%, hitting a new 52-week high of $25.82. The stock reported a 3-month average volume of 3.18 million shares compared with the volume of 11.98 million shares during the session. Huntsman Corp.'s shares traded at a PE ratio of 18.58 and were down 0.04% on YTD basis. Shares of the company have gained 14.00% in the last one month and 5.45% in the previous three months. The Materials Sector Index mapped a gain of 0.36% during the trading session and charted up by 8.60% during the last one month. The stock is trading above both its 50-day and 200-day moving averages. Huntsman Corp.'s 200-day moving average of 20.72 is below the 50-day moving average of $23.15. RSI of the companywas 65.98 at the end of the session. The complimentary notes on HUN can be downloaded as in PDF format at:
http://www.Investor-Edge.com/03072014/HUN/report.pdf
The Kroger Co.'s stock closed the day at $43.37, down 0.71% after hittinga new 52-weeks high of $45.25. The stock recorded a trading volume of 12.96 million shares, compared with the 3-month average volume of 4.31 million shares.The Kroger Co.'s shares are up 9.71% on YTD basis. Despite Thursday's decline, shares of the company have advanced 3.29% in the previous three trading sessions and 7.25% in the last three months. The stock has witnessed a gain of 17.98% in the last one month. The S&P 500 Consumer Staples Index mapped a loss of 0.04% during the session and gained 4.58% during the last one month. The stock is trading above its 50-day and 200-day moving averages.The Kroger Co.'s 200-day moving average of $38.72 is above the 50-day moving average of $38.38. Moreover, the company's shares were trading at the Relative Strength Index (RSI) of 83.86. Register for free on Investor-Edge and access the latest research on KR at:
http://www.Investor-Edge.com/03072014/KR/report.pdf
On Thursday, shares in Teva Pharmaceutical Industries Ltd edged 0.04% higher, to close the day at $49.82, hitting a new 52-week high of $51.41. The stock recorded a trading volume of 9.57 million shares, compared with the 3-month average volumes of 6.61 million shares. It traded between $49.77 and $51.41 during the session. The company's shares gained 24.30% on YTD basis. Shares of Teva Pharmaceutical have surged 11.48% in the last one month and 25.65% in the previous three months. The S&P 500 Health Care sector Index edged 0.67% lower during the session while the same has advanced 7.96% during the previous three months. The stock is trading above its 50-day and 200-day moving averages. Teva Pharmaceutical Industries Ltd's 200-day moving average of $40.39 is below the 50-day moving average of $44.11. Furthermore, the company's shares were trading at the Relative Strength Index (RSI) of 70.45. The complete research on TEVA is available for free at:
http://www.Investor-Edge.com/03072014/TEVA/report.pdf
About Investor-Edge.com
At Investor-Edge, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Investor-Edge comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.
=============
EDITOR NOTES:
=============
- This is not company news. We are an independent source and our views do not reflect the companies mentioned.
- Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
- This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
- If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] Investor-edge.com.
- For any urgent concerns or inquiries, please contact us at compliance [at] Investor-edge.com.
- Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] Investor-edge.com for consideration.
COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Investor-edge. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Investor-edge in this article or report according to the Procedures outlined by Investor-edge. Investor-edge is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Investor-edge makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Investor-edge is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Investor-edge whatsoever for any direct, indirect or consequential loss arising from the use of this document. Investor-edge expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Investor-edge does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Investor-Edge
